Nanovesicular carriers as alternative drug delivery systems: ethosomes in focus

Bibliography

• Mundargi RC, Babu VR, Rangaswamy V, et al. Nano/micro technologies for delivering macromolecular therapeutics using poly(D,L-lactide-co-glycolide) and its derivatives. J Control Release 2008;25(3):193-209
   Web of Science ®Google Scholar
• Roney C, Kulkarni P, Arora V, et al. Targeted nanoparticles for drug delivery through the blood–brain barrier for Alzheimer's disease. J Control Release 2005;108:193-214
   PubMed Web of Science ®Google Scholar
• Attama AA, Reichl S, Muller-Goymann CC. Sustained release and permeation of timolol from surface-modified solid-lipid nanoparticles through bioengineered human cornea. Curr Eye Res 2009;34:698-705
   PubMed Web of Science ®Google Scholar
• Kulkarni PV, Roney CA, Antich PP, et al. Quinoline-n-butylcyanoacrylate-based nanoparticles for brain targeting for the diagnosis of Alzheimer's disease. WIREs Nanomed Nanobiotechnol 2010;2:35-47
   PubMed Web of Science ®Google Scholar
• Semete-Makokotlela B, Kalombo L, Hayeshi R, et al. Nanomedicine for improved efficacy of tuberculosis drugs. 4th ANDI Stakeholders Meeting; Addis Ababa; 24 – 28 October 2011
   Google Scholar
• GuhaSarkar S, Banerjee R. Intravesical drug delivery: challenges, current status, opportunities and novel strategies. J Control Release 2010;148:147-59
   PubMed Web of Science ®Google Scholar
• Pinto Reis C, Nuefeld RJ, Ribeiro AJ, et al. Nanoencapsulation 1. Methods for preparation of drug-loaded polymeric nanoparticles. Nanomedicine 2006;2:8-21
   PubMed Web of Science ®Google Scholar
• Hatto P. ISO concensus definitions relevant to nanomaterials and nanotechnologies. 4th Annual Nano Safety for Success Dialogue. ISO TC 229and BSI NTI/1 Nanotechnologies standardization committees. 29th and 30th March 2011. Brussels. Available from: http://ec.europa.eu/health/nanotechnology [Last accessed 15 Augest 2012]
   Google Scholar
• Gupta M, Agrawal U, Vyas SP. Nanocarrier-based topical drug delivery for the treatment of skin diseases. Expert Opin Drug Deliv 2012;9(7):783-804
   PubMed Web of Science ®Google Scholar
• Schreier H, Bouwstra J. Liposomes and niosomes as topical drug carriers: dermal and transdermal drug delivery. J Control Release 1994;30:1-15
   Web of Science ®Google Scholar
• Vyas SP, Khatri K, Mishra V. Vesicular carrier construct for topical immunization. Expert Opin Drug Deliv 2007;4(4):341-8
   PubMed Web of Science ®Google Scholar
• Touitou E, Dayan N, Bergelson L, et al. Ethosomes – novel vesicular carriers for enhanced delivery: characterization and skin penetration properties. J Control Release 2000;65:403-18
   PubMed Web of Science ®Google Scholar
• Horinaga M, Harsch KM, Fukuyama R, et al. Intravesical interleukin-12 gene therapy in an orthotopic bladder cancer model. Urology 2005;66:461-6
   PubMed Web of Science ®Google Scholar
• Horwitz E, Pisanty S, Czerninski R, et al. A clinical evaluation of a novel liposomal carrier for acyclovir in the topical treatment of recurrent herpes labialis. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1999;88:700-5
   Web of Science ®Google Scholar
• Serikawa T, Kikuchi A, Sugaya S, et al. In vitro and in vivo evaluation of novel cationic liposomes utilized for cancer gene therapy. J Control Release 2006;113(3):255-60
   PubMed Web of Science ®Google Scholar
• Barry B. Breaching the skin' barrier to drugs. Nat Biotechnol 2004;22:165-7
   PubMed Web of Science ®Google Scholar
• Honeywell-Nguyen PL, Bouwstra JA. Vesicles as a tool for transdermal and dermal delivery. Drug Discov Today 2005;2:67-74
   Google Scholar
• Elsayed MMA, Abdallah OY, Naggar VF, et al. Lipid vesicles for skin delivery of drugs: reviewing three decades of research. Int J Pharm 2007a;332:1-16
   PubMed Web of Science ®Google Scholar
• Ainbinder D, Touitou E. Testosterone ethosomes for enhanced transdermal delivery. Drug Deliv 2005;12:297-303
   PubMed Web of Science ®Google Scholar
• Paolino D, Lucania G, Mardente D, et al. Ethosomes for skin delivery of ammonium glycyrrhizinate: in vitro percutaneous permeation through human skin and in vivo anti-inflammatory activity on human volunteers. J Control Release 2005;106:99-110
   PubMed Web of Science ®Google Scholar
• Dayan N, Touitou E. Carriers for skin delivery of trihexyphenidyl HCl: ethosomes vs. liposomes. Biomaterials 2000;21:1879-85
   PubMed Web of Science ®Google Scholar
• Lopez-Pinto JM, Gonzalez-Rodriguez ML, Rabasco AM. Effect of cholesterol and ethanol on dermal delivery from DPPC liposomes. Int J Pharm 2005;298:1-12
   PubMed Web of Science ®Google Scholar
• Elsayed MM, Abdallah OY, Naggar VF, et al. Deformable liposomes and ethosomes as carriers for skin delivery of ketotifen. Pharmazie 2007b;62:133-7
   PubMed Web of Science ®Google Scholar
• Walsh AE. Gas vesicles. Microbiol Rev 1994;58(1):94-144
   PubMedGoogle Scholar
• Preiss MR, Bothun GD. Stimuli-responsive liposome nanoparticle assemblies. Expert Opin Drug Deliv 2011;8(8):1025-40
   PubMed Web of Science ®Google Scholar
• Alberts B, Johnson A, Lewis J, et al. The lipid bilayer. In: Molecular biology of the cell. 4th editon. Available from: www.ncbi.nlm.nih.gov/books/NBK26871] [Last accessed 11 September 2013]
   Google Scholar
• Cevc G. Transfersomes, liposomes and other lipid suspensions on the skin: permeation enhancement, vesicle penetration, and transdermal drug delivery. Crit Rev Ther Drug Carrier Syst 1996;13(3-4):257-388
   PubMed Web of Science ®Google Scholar
• Kidd PM. Phytosome®: A technical revolution in phytomedicine. 2011. Available from: www.indena.com [Last accessed 10 September 2011]
   Google Scholar
• Erdogan S, Ozer AY, Bilgili H. In vivo behaviour of vesicular urokinase. Int J Pharm 2005;295:1-6
   PubMed Web of Science ®Google Scholar
• Waelti E, Wegmann N, Schwaninger R, et al. Targeting her-2/neu with antirat Neu virosomes for cancer therapy. Cancer Res 2002;62:437-44
   PubMed Web of Science ®Google Scholar
• Hofer U, Lehmann AD, Waelti E, et al. Virosomes can enter cells by non-phagocytic mechanisms. J Liposome Res 2009;19(4):301-9
   PubMed Web of Science ®Google Scholar
• Dragicevic-Curic N, Scheglmann D, Albrecht V, Fahr A. Temoporfin-loaded invasomes: development, characterization and in vitro skin penetration studies. J Control Release 2008;127:59-69
   PubMed Web of Science ®Google Scholar
• Sinico C, Fadda AM. Vesicular carriers for transdermal drug delivery. Expert Opin Drug Deliv 2009;6(8):813-25
   PubMed Web of Science ®Google Scholar
• Touitou E. Composition of applying active substances to or through the skin. US5716638; 1996
   Google Scholar
• Foldvari M, Gesztes A, Mezei M, et al. Topical liposomal local anesthetics: design, optimization and evaluation of formulations. Drug Dev Ind Pharm 1993;19:2499-517
   Web of Science ®Google Scholar
• Araujoa J, Vega E, Lopes C, et al. Effect of polymer viscosity on physicochemical properties and ocular tolerance of FB-loaded PLGA nanospheres. Colloids Surf B Biointerfaces 2009;72:48-56
   PubMed Web of Science ®Google Scholar
• Jain S, Mishra D, Kuksal A. Ethosomes: A recent approach in transdermal/topical delivery. In vesicular approach for drug delivery into or across the skin: current status and future prospects. AAPS Pharmainfo 2007a;5(2). Available from: www.pharmainfo.net [Last accessed 21 April 2009]
   Google Scholar
• Bendas ER, Tadros MI. Enhanced transdermal delivery of salbutamol sulfate via ethosomes. AAPS PharmSciTech 2007;8(4):article107. E1-8
   Google Scholar
• Maestrelli F, Capasso G, Gonzalez-Rodriguez ML, et al. Effect of preparation technique on the properties and in vivo efficacy of benzocaine-loaded ethosomes. J Liposome Res 2009;19(4):253-60
   PubMed Web of Science ®Google Scholar
• Mbah CC. Formulation and evaluation of ethosomes for enhanced delivery of four bioactive agents. A PhD Thesis submitted to the Department of Pharmaceutics, University of Nigeria, Nsukka, 2013 ( Unpublished)
   Google Scholar
• Coderch L, Fonollosa J, De Pera M, et al. Influence of cholesterol on liposome fluidity by EPR: relationship with percutaneous absorption. J Control Release 2000;68:85-95
   PubMed Web of Science ®Google Scholar
• Socaciu C, Jessel R, Diehl HA. Competitive carotenoid and cholesterol incorporation into liposomes: effects on membrane phase transition, fluidity, polarity and anisotropy. Chem Phys Lipids 2002;106:76-88
   Google Scholar
• Maurer N, Wong KF, Stark H, et al. Spontaneous entrapment of polynucleotides upon electrostatic interaction with ethanol-desestabilized cationic liposomes. Biophys J 2001;80:2310-26
   PubMed Web of Science ®Google Scholar
• Foldvari M. Non-invasive administration of drugs through the skin: challenges in delivery system design. Pharm Sci Tech Today 2000;3(12):417-25
   PubMedGoogle Scholar
• Yarosh DB. Liposome-encapsulated enzymes for DNA repair. In: Braun-Falco O, Korting HC, Maibach H, editors. Liposome dermatics. Springer-Verlag; Heidelberg: 1992. p. 258-69
   Google Scholar
• El Maghraby GM, Barry BW, Williams AC. Liposomes and skin: from drug delivery to model membranes. Eur J Pharm Sci 2008;34:203-22
   PubMed Web of Science ®Google Scholar
• Elias PM. Epidermal lipids; membranes and keratinization. Int J Dermatol 1981;20:1-9
   PubMed Web of Science ®Google Scholar
• Barry BW. Lipid protein partitioning theory of skin penetration enhancement. J Control Release 1991;15:237-48
   Web of Science ®Google Scholar
• Barry BW. Novel mechanisms and devices to enable successful transdermal drug delivery. Eur J Pharm Sci 2001;14(2):101-14
   PubMed Web of Science ®Google Scholar
• Al-Obaidi H, Nasseri B, Florence AT. Dynamics of lipid microparticles inside lipid vesicles: movement in confined spaces. J Drug Target 2010;18(10):821-30
   PubMed Web of Science ®Google Scholar
• Shakeel F, Baboota S, Ahuja A, et al. Skin permeation mechanism and bioavailability enhancement of celecoxib from transdermally applied nanoemulsion. J Nanobiotechnol 2008;6:8
   PubMedGoogle Scholar
• Liang W, Levchenko TS, Torchilin VP. Encapsulation of ATP into liposomes by different methods: optimization of the procedure. J Microencapsul 2004;21:251-61
   PubMed Web of Science ®Google Scholar
• Van Winden ECA, Zuidam NJ, Crommelin DJA. Strategies for large scale production and optimized stability of pharmaceutical liposomes developed for parenteral use. In: Lasic DD, Papahadjopoulos D, editors. Medical applications of liposomes. Elsevier; Amsterdam: 1998. p. 567-604
   Google Scholar
• Payne NI, Timmins P, Ambrose CV. Proliposomes: a novel solution to an old problem. J Pharm Sci 1986;75(4):325-9
   PubMed Web of Science ®Google Scholar
• Hu C, Rhodes DG. Proniosomes: a novel drug carrier preparation. Int J Pharm 1999;185(1):23-35
   PubMed Web of Science ®Google Scholar
• Blazek-Welsh AI, Rhodes DG. Maltodextrin-based proniosomes. AAPS PharmSci 2001;3(1):article1:1-8. Available from: http://www.pharmsci.org
   Google Scholar
• Jain S, Sapre R, Tiwary AK, et al. Proultraflexible lipid vesicles for effective transdermal delivery of levonorgestrel: development, characterization and performance evaluation. AAPS PharmSciTech 2005;6(3):article 64: E513-522. Available from: http://www.aapspharmscitech.org
   Google Scholar
• Samah NA, Williams N, Heard CM. Nanogel particulates located within diffusion cell receptor phases following topical application demonstrates uptake into and migration across skin. Int J Pharm 2010;401:72-8
   PubMed Web of Science ®Google Scholar
• Sentjurc M, Vrhovnik K, Kristl J. Liposomes as a topical delivery system: the role of size on transport studied by ESR imaging method. J Control Release 1999;59:87-97
   PubMed Web of Science ®Google Scholar
• NanoSight Ltd. Nanoparticle tracking analysis. Available from: www.nanosight.com [Last accessed 13 April 2012]
   Google Scholar
• Stark B, Pabst G, Prassl R. Long-term stability of sterically stabilized liposomes by freezing and freeze-drying: effects of cryoprotectants on structure. Eur J Pharm Sci 2010;41:546-55
   PubMed Web of Science ®Google Scholar
• Nakhla T, Marek M, Kovalcik T. Issues associated with large-scale production of liposomal formulations. Drug Deliv Technol 2002;2:1-6
   Google Scholar
• Maestrelli F, González-Rodríguez ML, Rabasco AM, et al. Effect of preparation technique on the properties of liposomes encapsulating ketoprofen-cyclodextrin complexes aimed for transdermal delivery. Int J Pharm 2006;312:53-60
   PubMed Web of Science ®Google Scholar
• Celia C, Trapasso E, Cosco D, et al. Turbiscan Lab® Expert analysis of the stability of ethosomes® and ultradeformable liposomes containing a bilayer fluidizing agent. Colloids Surf B Biointerfaces 2009;72:155-60
   PubMed Web of Science ®Google Scholar
• Feng S, Huang G. Effects of emulsifiers on the controlled release of paclitaxel (Taxol) from nanospheres of biodegradable polymers. J Control Release 2001;71:53-69
   PubMed Web of Science ®Google Scholar
• Lasic D, Weiner N, Riaz M, et al. Liposomes. In: Lieberman A, Rieger M, Banker G, editors. Pharmaceutical dosage forms: Disperse systems. Volume 3. Marcel Dekker; New York: 1998. p. 43-86
   Google Scholar
• Peikov V, Ugwu S, Parmar M, et al. pH-dependent association of SN-38 with lipid bilayers of a novel liposomal formulation. Int J Pharm 2005;299:92-9
   PubMed Web of Science ®Google Scholar
• Marianecci C, Paolino D, Celia C, et al. Non-ionic surfactant vesicles in pulmonary glucocorticoid delivery: characterization and interaction with human lung fibroblasts. J Control Release 2010;147:127-35
   PubMed Web of Science ®Google Scholar
• Borges O, Borchard G, Verhoef JC, et al. Preparation of coated nanoparticles for a new mucosal vaccine delivery system. Int J Pharm 2005;299:155-66
   PubMed Web of Science ®Google Scholar
• Elhissi AM, O'Neill MA, Roberts SA, et al. A calorimetric study of dimyristoylphosphatidylcholine phase transitions and steroid–liposome interactions for liposomes prepared by thin film and proliposome methods. Int J Pharm 2006;320:124-30
   PubMed Web of Science ®Google Scholar
• Balenga NAB. Controlled release of DNA vaccines: does in vitro release profile correlate with immune response? Med Hypothes 2006;66:864-5
   PubMed Web of Science ®Google Scholar
• Wang PS, Levin R, Zhao SZ, et al. Urinary antispasmodic use and the risks of ventricular arrhythmia and sudden death in older patients. J Am Geriatr Soc 2002;50:117-24
   PubMed Web of Science ®Google Scholar
• Blanco-Prietoa MJ, Besseghir K, Orsolini P, et al. Importance of the test medium for the release kinetics of a somatostatin analogue from poly(-lactide-co-glycolide) microspheres. Int J Pharm 1999;184:243-50
   PubMed Web of Science ®Google Scholar
• Bouwstra JA, Honeywell-Nguyen PL, Gooris GS, et al. Structure of the skin barrier and its modulation by vesicular formulations. Prog Lipid Res 2003;42:1-36
   PubMed Web of Science ®Google Scholar
• Wu PC, Tsai YH, Liao CC, et al. The characterization and biodistribution of cefoxitin-loaded liposomes. Int J Pharm 2004;271:31-9
   PubMed Web of Science ®Google Scholar
• Franz TJ, Lehman PA. Prototype testing. Transderm 2011;3(6):12-16. Available from: www.transdermalmag.com
   Google Scholar
• Kang MJ, Eum JY, Park SH, et al. Pep-1 peptide-conjugated elastic liposomal formulation of taxifolin glycoside for the treatment of atopic dermatitis in NC/Nga mice. Int J Pharm 2010;402:198-204
   PubMed Web of Science ®Google Scholar
• El Maghraby GM, Williams AC, Barry BW. Oestradiol skin delivery from ultradeformable liposomes: refinement of surfactant concentration. Int J Pharm 2000a;196:63-74
   PubMed Web of Science ®Google Scholar
• Touitou E, Godin B, Dayan N, et al. Intracellular delivery mediated by an ethosomal carrier. Biomaterials 2001;22:3053-9
   PubMed Web of Science ®Google Scholar
• Cevc G, Blume G, Schatzlein A, et al. The skin: a pathway for systemic treatment with patches and lipid-base agent carriers. Adv Drug Deliv Rev 1996;18:349-78
   Web of Science ®Google Scholar
• Jain S, Tiwary AK, Sapra B, Jain NK. Formulation and evaluation of ethosomes for transdermal delivery of lamivudine. AAPS PharmSciTech 2007b;8(4):Article111
   Google Scholar
• Aulton ME. Disperse systems: in pharmaceutics. In: Aulton ME, editor. The science of dosage form design. Churchill Livingstone; Edinburgh: 1999. p. 81-118; 571
   Google Scholar
• Yu T, Malcolm K, Woolfson D, et al. Vaginal gel drug delivery systems: understanding rheological characteristics and performance. Expert Opin Drug Deliv 2011;8(10):1309-22
   PubMed Web of Science ®Google Scholar
• Nguyen CA, Konan-Kouakou YN, Allemann E, et al. Preparation of surfactant-free nanoparticles of methacrylic acid copolymers used for film coating. AAPS PharmSciTech 2006;7(3): article63: E1-E7 Available from: http://www.aapspharmscitech.org
   Google Scholar
• Schiffelers RM, Metselaar JM, Fens MHAM, et al. Liposome-encapsulated prednisolone phosphate inhibits growth of established tumors in mice. Neoplasia 2005;7(2):118-27
   PubMed Web of Science ®Google Scholar
• Builders PF, Mbah CC, Attama AA. Intrinsic and functional properties of a gelling gum from dioclea reflexa: a potential pharmaceutical excipient. Br J Pharm Res 2012;2(1):50-68
   Google Scholar
• Schwarz JC, Weixelbaum A, Pagitsch E, et al. Nanocarriers for dermal drug delivery: influence of preparation method, carrier type and rheological properties. Int J Pharm 2012;437:83-8
   PubMed Web of Science ®Google Scholar
• Boncheva M, Damien F, Normand V. Molecular organization of the lipid matrix in intact stratum corneum using ATR-FTIR spectroscopy. Biochim Biophys Acta 2008;1778:1344-55
   PubMed Web of Science ®Google Scholar
• Agrawal Y, Petkar KC, Sawant KK. Development, evaluation and clinical studies of Acitretin loaded nanostructured lipid carriers for topical treatment of psoriasis. Int J Pharm 2010;401:93-102
   PubMed Web of Science ®Google Scholar
• Karavelidis V, Giliopoulos D, Karavas E, et al. Nanoencapsulation of a water soluble drug in biocompatible polyesters: effects of polyesters melting point and glass transition temperature on drug release behavior. Eur J Pharm Sci 2010;41:636-43
   PubMed Web of Science ®Google Scholar
• Sarmento B, Ferreira D, Veiga V, et al. Characterisation of insulin-loaded alginate nanoparticles produced by ionotropic pre-gelation through DSC and FTIR studies. Carbohydr Polym 2006;66(1):1-7
   Web of Science ®Google Scholar
• Zhang A, Xuan T, Parmar M, et al. Development and characterization of a novel liposome-based formulation of SN-38. Int J Pharm 2004;270:93-107
   PubMed Web of Science ®Google Scholar
• Lau KG, Hattori Y, Chopra S, et al. Ultra-deformable liposomes containing bleomycin: in vitro stability and toxicity on human cutaneous keratinocyte cell lines. Int J Pharm 2005;300:4-12
   PubMed Web of Science ®Google Scholar
• Attia IA, El-Gizawy SA, Fouda MA, et al. Influence of niosomal formulation on the oral bioavailability of acyclovir in rabbits. AAPS PharmSciTech 2007;8(4):Article106. Available from: http://www.aapspharmscitech.org
   Google Scholar
• Ram N, Pattabiraman M, Vijayan C. Effect of ellipticity on Hanle electromagnetically induced absorption and transparency resonances with longitudinal and transverse magnetic field. Phys Rev 2010;A82(3):033417. Available from: http://link.aps.org/doi/10.1103/physRevA82.033417
   Google Scholar
• Rao Y, Zheng F, Zhang X, et al. In vitro percutaneous permeation and skin accumulation of finasteride using vesicular ethosomal carriers. AAPS Pharm Sci Tech 2008;9930:860-5
   Web of Science ®Google Scholar
• Godin B, Touitou E. Mechanism of bacitracin permeation enhancement through the skin and cellular membranes from an ethosomal carrier. J Control Release 2004;94:365-79
   PubMed Web of Science ®Google Scholar
• Godin B, Touitou E, Rubinstein E, et al. A new approach for treatment of deep skin infections by an ethosomal antibiotic preparation: an in vivo study. J Antimicrob Chemotherap 2005;55:989-94
   PubMed Web of Science ®Google Scholar
• Cevc G, Blume G, Schatzlein A. Transfersomes-mediated transepidermal delivery improves the regio-specific and biological activity of corticosteroids in vivo. J Control Release 1997;45:211-36
   Web of Science ®Google Scholar
• Cevc G, Blume G. New, highly efficient formulation of diclofenac for the topical, transdermal administration in ultradeformable drug carriers, Transfersomes. Biochim Biophys Acta 2001;1514:191-205
   PubMed Web of Science ®Google Scholar
• Cevc G, Gebauer D, Stieber J, et al. Ultraflexible vesicles, Transfersomes, have an extremely low pore penetration resistance and transport therapeutic amounts of insulin across the intact mammalian skin. Biochim Biophys Acta 1998;1368:201-15
   PubMed Web of Science ®Google Scholar
• Paul A, Cevc G, Bachhawat BK. Transdermal immunisation with an integral membrane component, gap junction protein, by means of ultradeformable drug carriers, transfersomes. Vaccine 1998;16:188-95
   PubMed Web of Science ®Google Scholar
• Verma P, Pathak K. Therapeutic and cosmeceutical potential of ethosomes: an overview. J Adv Pharm Tech Res 2010;1:274-82
   PubMedGoogle Scholar
• Gabizon A, Catane R, Uziely B, et al. Prolonged circulation time and enhanced accumulation in malignant exudates of doxorubicin encapsulated in polyethylene-glycol coated liposomes. Cancer Res 1994;54(4):987-92
   PubMed Web of Science ®Google Scholar
• Bawarski WE, Chidlowsky E, Bharali JD, et al. Emerging nanopharmaceuticals. Nanomedicine 2008;4:273-82
   PubMed Web of Science ®Google Scholar
• Barea MJ, Jekins MJ, Gaber MH, et al. Evaluation of liposomes coated with a pH responsive polymer. Int J Pharm 2010;402:89-94
   PubMed Web of Science ®Google Scholar
• Alexis F, Pridgen EM, Langer R, et al. Nanoparticle technologies for cancer therapy. In: Farokhzad OC, Schäfer-Korting M, editors. Handbook of experimental pharmacology. Springer-Verlag; Berlin Heidelberg: 2010. DOI 10.1007/978-3-642-00477-3_2, #
   Google Scholar
• Ajazuddin SS. Applications of novel drug delivery system for herbal formulations. Fitoterapia 2010;81:680-9
   PubMed Web of Science ®Google Scholar
• Goyal A, Kumar S, Nagpal M, et al. Potential of novel drug delivery systems for herbal drugs. Ind J Pharm Edu Res 2011;45(3):225-35
   Web of Science ®Google Scholar